Ahmed Bennis/X
Nov 17, 2026, 23:34
Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X about a recent article by John W. Eikelboom, published in NEJM, adding:
“Aspirin Therapy — Enough after Arthroplasty?
Results from the EPCAT III and PEPPER trials suggest that aspirin therapy from the outset after surgery is a reasonable option for many patients at standard risk for thrombosis, but the results do not establish that aspirin and anticoagulants provide equivalent protection against VTE.”
Title: Aspirin Therapy — Enough after Arthroplasty?
Authors: John W. Eikelboom

Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy